# Endovascular Treatment or Standard Medical Care for Cerebral Venous Sinus Thrombosis(ESCORT)

> **NCT06583889** · NA · RECRUITING · sponsor: **Beijing Tiantan Hospital** · enrollment: 224 (estimated)

## Conditions studied

- Cerebral Venous Sinus Thrombosis

## Interventions

- **DRUG:** Heparin
- **PROCEDURE:** Endovascular treatment

## Key facts

- **NCT ID:** NCT06583889
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-09
- **Primary completion:** 2029-01
- **Final completion:** 2029-08
- **Target enrollment:** 224 (ESTIMATED)
- **Last updated:** 2024-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06583889

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06583889, "Endovascular Treatment or Standard Medical Care for Cerebral Venous Sinus Thrombosis(ESCORT)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06583889. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*